Greenlight® photoselective vaporisation for benign prostatic hyperplasia: A systematic review;Traitement de l'hyperplasie bénigne de prostate par photovaporisation au laser Greenlight® : Analyse de la littérature

Progres en Urologie

Volumn 23, Issue 2, 2013, Pages 77-87

  Misrai V ^a   Roupret M ^b   Guillotreau, J ^a   Bordier, B ^a   Bruyere F ^c  

^a CLINIQUE PASTEUR   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CHU BRETONNEAU   (France)

Author keywords

Benign prostate hypertrophy; Endoscopic surgery; IPSS score; Laser; Morbidity

Indexed keywords

AGED; EVIDENCE BASED MEDICINE; HUMAN; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; PROGNOSIS; PROSTATE HYPERTROPHY; PROSTATECTOMY; SHORT SURVEY; TIME; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

AGED; EVIDENCE-BASED MEDICINE; HUMANS; LASER THERAPY; MALE; PROGNOSIS; PROSTATECTOMY; PROSTATIC HYPERPLASIA; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 84872831953     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2012.10.013     Document Type: Short Survey

References (64)

1. de la Rosette J.J., Alivizatos G., Madersbacher S., Perachino M., Thomas D., Desgrandchamps F., et al. EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2001, 40:256-263.
2. Barry Delongchamps N., Robert G., Descazeaud A., Cornu J.N., Rahmene Azzouzi A., Haillot O., Devonec M., Fourmarier M., Ballereau C., Lukacs B., Dumonceau O., Saussine C., de la Taille A. Traitement chirurgical de l'hyperplasie beónigne de la prostate par laser : revue de litteórature du CTMH de l'AFU. Prog Urol 2012, 22:80-86. Le comité des troubles mictionnels de l'homme de l'Association Française d'Urologie.
3. Malek R.S., Kuntzman R.S., Barrett D.M. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000, 163(6):1730-1733.
4. Bruyere F. Un point technique sur la photovaporisation prostatique à l'aide du laser Greenlight. Prog Urol 2008, 18:19-23.
5. Madersbacher S. Editorial comment on: GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008, 54:901.
6. Ruszat R., Seitz M., Wyler S.F., Abe C., Rieken M., Reich O., et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008, 54:893-901.
7. Bruyere F. La photovaporisation laser de la prostate. Prog Urol 2011, 21:808-810.
8. Malek R.S., Barrett D.M., Kuntzman R.S. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24hours later. Urology 1998, 51:254-256.
9. Hai M.A., Malek R.S. Photoselective vaporization of the prostate: initial experience with a new 80W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003, 17:93-96.
10. Gomez Sancha F., Bachmann A., Choi B.B., Tabatabaei S., Muir G.H. Photoselective vaporization of the prostate (GreenLight PV): lessons learnt after 3500 procedures. Prostate Cancer Prostatic Dis 2007, 10:316-322.
11. Bachmann A., Muir G.H., Collins E.J., Choi B.B., Tabatabaei S., Reich O.M., et al. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 2012, 61:600-607.
12. Zorn K.C., Liberman D. GreenLight 180W XPS photovaporization of the prostate: how I do it. Can J Urol 2011, 18:5918-5926.
13. Spaliviero M., Araki M., Culkin D.J., Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol 2009, 23:495-502.
14. Sandhu J.S., Ng C., Vanderbrink B.A., Egan C., Kaplan S.A., Te A.E. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004, 64:1155-1159.
15. Bachmann A., Ruszat R., Wyler S., Reich O., Seifert H.H., Muller A., et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 2005, 47:798-804.
16. Kauffman E.C., Kang H.W., Choi B.B. The effect of laser-fiber sweeping speed on the efficiency of photoselective vaporization of the prostate in an ex vivo bovine model. J Endourol 2009, 23:1429-1435.
17. Ko W.J., Choi B.B., Kang H.W., Rajabhandharaks D., Rutman M., Osterberg E.C. Defining optimal laser-fiber sweeping angle for effective tissue vaporization using 180W 532nm lithium triborate laser. J Endourol 2012, 26:313-317.
18. Osterberg E.C., Kauffman E.C., Kang H.W., Koullick E., Choi B.B. Optimal laser fiber rotational movement during photoselective vaporization of the prostate in a bovine ex-vivo animal model. J Endourol 2011, 25:1209-1215.
19. Bruyere F. Quand faut-il arrêter une photovaporisation prostatique par laser greenlight?. Prog Urol 2011, 21:387-388.
20. ® XPS (180W). Prog Urol 2011, 21:383-386.
21. Carter A., Sells H., Speakman M., Ewings P., MacDonagh R., O'Boyle P. A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 1999, 83:254-259.
22. Lukacs B., Loeffler J., Bruyere F., Blanchet P., Gelet A., Coloby P., et al. Photoselective vaporization of the prostate with Greenlight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 2012, 61:1165-1173.
23. Lourenco T., Armstrong N., N'Dow J., Nabi G., Deverill M., Pickard R., et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 2008, 12:1-146.
24. Thangasamy I.A., Chalasani V., Bachmann A., Woo H.H. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 2012, 62:315-323.
25. Pereira-Correia J.A., de Moraes Sousa K.D., Santos J.B., de Morais Perpetuo D., Lopes-da-Silva L.F., Krambeck R.L., et al. GreenLight HPS 120-W laser vaporization vs transurethral resection of the prostate (<60mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 2012, 18.
26. Tasci A.I., Ilbey Y.O., Luleci H., Cicekler O., Sahin S., Cevik C., et al. 120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. Urology 2011, 78:134-140.
27. Capitan C., Blazquez C., Martin M.D., Hernandez V., de la Pena E., Llorente C. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011, 60:734-739.
28. Horasanli K., Silay M.S., Altay B., Tanriverdi O., Sarica K., Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70mL: a short-term prospective randomized trial. Urology 2008, 71:247-251.
29. Hamann M.F., Naumann C.M., Seif C., van der Horst C., Junemann K.P., Braun P.M. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Eur Urol 2008, 54:902-907.
30. Rajbabu K., Chandrasekara S.K., Barber N.J., Walsh K., Muir G.H. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of>100mL. BJU Int 2007, 100:593-598.
31. Matoka D.J., Averch T.D. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate. Can J Urol 2007, 14:3710-3714.
32. Rieken M., Bonkat G., Rentsch C., Wyler S., Gasser T., Bachmann A. Long-term results of laser vaporization of the prostate with the 80-W KTP-laser. Urology 2009, 74:S69.
33. Te A.E., Malloy T.R., Stein B.S., Ulchaker J.C., Nseyo U.O., Hai M.A. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006, 97:1229-1233.
34. Berger J., Robert G., Descazeaud A. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy. Curr Urol Rep 2010, 11:236-244.
35. Ruszat R., Wyler S., Forster T., Reich O., Stief C.G., Gasser T.C., et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007, 51:1031-1038.
36. Tugcu V., Tasci A.I., Sahin S., Zorluoglu F. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 2008, 22:1519-1525.
37. Reich O., Bachmann A., Siebels M., Hofstetter A., Stief C.G., Sulser T. High power (80W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005, 173:158-160.
38. Sandhu J.S., Ng C.K., Gonzalez R.R., Kaplan S.A., Te A.E. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005, 19:1196-1198.
39. Sarica K., Alkan E., Luleci H., Tasci A.I. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 2005, 19:1199-1202.
40. Descazeaud A., Robert G., Azzousi A.R., Ballereau C., Lukacs B., Haillot O., et al. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 2009, 103:1162-1165.
41. Paick J.S., Um J.M., Kim S.W., Ku J.H. Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med 2007, 4:1701-1707.
42. Bruyere F., Puichaud A., Pereira H., Faivre d'Arcier B., Rouanet A., Floc'h A.P., et al. Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 2010, 58:207-211.
43. Kavoussi P.K., Hermans M.R. Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. J Sex Med 2008, 5:2669-2671.
44. Reich O., Bachmann A., Schneede P., Zaak D., Sulser T., Hofstetter A. Experimental comparison of high power (80W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004, 171:2502-2504.
45. Robinson D., Aus G., Bak J., Gorecki T., Herder A., Rosell J., Varenhorst E. Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007, 41:103-109.
46. Andrèn O., Garmo H., Mucci L., Andersson S.O., Johansson J.E., Fall K. Incidence and mortality of incidental prostate cancer: a Swedish register-based study. Br J Cancer 2009, 100:170-173.
47. Voigt S., Hüttig F., Koch R., Propping S., Propping C., Grimm M.O., Wirth M. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia?. Prostate 2011, 71:1325-1331.
48. Bouchier-Hayes D.M., Van Appledorn S., Bugeja P., Crowe H., Challacombe B., Costello A.J. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 2010, 105:964-969.
49. Goh A.C., Gonzalez R.R. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis. J Urol 2010, 183:1469-1473.
50. Stafinski T., Menon D., Harris K., Md G.G., Jhangri G. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia. Can Urol Assoc J 2008, 2:124-134.
51. Ruszat R., Sukser T., Scifert H.H., et al. Photoselective vaporization (PVP) versus transurethral electroresection of the prostate (TURP): a comparing cost analysis. EAU Congress Paris Abstract No. 9996. Eur Urol Suppl 2006, 5:271.
52. Malek R.S., Kuntzman R.S., Barrett D.M. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005, 174:1344-1348.
53. Heinrich E., Schiefelbein F., Schoen G. Technique and short-term outcome of green light laser (KTP, 80W) vaporisation of the prostate. Eur Urol 2007, 52:1632-1637.
54. Ruszat R., Seitz M., Wyler S.F., Abe C., Rieken M., Reich O., Gasser T.C., Bachmann A. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008, 54:893-901.
55. Alivizatos G., Skolarikos A., Chalikopoulos D., Papachristou C., Sopilidis O., Dellis A., Kastriotis I., Deliveliotis C. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas>80mL: 12-mo results of a randomized prospective study. Eur Urol 2008, 54:427-437.
56. Pfitzenmaier J., Gilfrich C., Pritsch M., Herrmann D., Buse S., Haferkamp A., Djakovic N., Pahernik S., Hohenfellner M. Vaporization of prostates of>or =80mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of<80mL. BJU Int 2008, 102:322-327.
57. Chiang P.H., Chen C.H., Kang C.H., Chuang Y.C. GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med 2010, 42:624-629.
58. Woo H.H., Hossack T.A. Photoselective vaporization for prostatic obstruction with the 120-W lithium triborate laser: 1-year clinical outcomes. Int J Urol 2011, 18:162-165.
59. Chung A.S., Chabert C., Yap H.W., Lam J., Awad N., Nuwayhid F., Redwig F., Rashid P., Woo H.H. Photoselective vaporization of the prostate using the 180W lithium triborate laser. ANZ J Surg 2012, 28. [Epub ahead of print].
60. Al-Ansari A., Younes N., Sampige V.P., Al-Rumaihi K., Ghafouri A., Gul T., Shokeir A.A. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 2010, 58:349-355.
61. Mai K.T., Isotalo P.A., Green J., Perkins D.G., Morash C., Collins JP Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening. Arch Pathol Lab Med 2000, 124:1454-1456.
62. Trpkov K., Thompson J., Kulaga A., Yilmaz A. How much tissue sampling is required when unsuspected minimal prostate carcinoma is identified on transurethral resection?. Arch Pathol Lab Med. 2008, 132:1313-1316.
63. Helfand B.T., Anderson C.B., Fought A., Kim D.Y., Vyas A., McVary K.T. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Urology 2009, 74:177-183.
64. Dellavedova T., Ponzano R., Racca L., Minuzzi F., Domínguez M. Prostate cancer as incidental finding in transurethral resection. Arch Esp Urol 2010, 63:855-861.